Independent
Tenure on this board
2.3 yrs
Meeting calendar
PACS · Annual meeting · Friday, December 19, 2025
Pacs Group Inc
2 nominees · 4 ballot items.
Election of two Class I directors, ratification of Ernst & Young LLP as independent auditors for the 2025 fiscal year, advisory vote on the frequency of future Say-on-Pay votes, and advisory vote on the compensation of PACS Group, Inc.’s named executive officers (Say-on-Pay).
Market cap
$7.3B
1Y TSR
+242.7%
Board grade
B-
Record date
Nov 10, 2025
Filing
DEF 14A
Meeting concluded · Dec 19, 2025
Follow how the vote landed and what changed on Pacs Group Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of Directors
ManagementBoard: FORVote to elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.
- 2
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
- 3
Approval, on an Advisory (Non-Binding) Basis, of the Frequency of Future Advisory Votes on the Compensation of our Named Executive Officers
ManagementBoard: FORSay-on-Frequency: stockholders may specify whether future Say-on-Pay votes occur every year, every two years, or every three years; the Board recommends ONE YEAR.
- 4
Approval, on an Advisory (Non-Binding) Basis, of the Compensation of our Named Executive Officers
ManagementBoard: FORSay-on-Pay advisory vote on the compensation of PACS Group, Inc.’s named executive officers as disclosed in the proxy statement; the vote is advisory and non-binding.
Director elections
Nominees on the ballot2
Independent
Tenure on this board
3.0 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | COHEN STEERS, INC. | 5.8% | 9,123,136 | $293M |
| 2 | FMR LLC | 2.9% | 4,642,889 | $149M |
| 3 | Alyeska Investment Group, L.P. | 1.9% | 3,002,671 | $96M |
| 4 | Crewe Advisors LLC | 1.7% | 2,754,179 | $88M |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2% | 1,861,206 | $60M |
| 6 | AMERICAN CENTURY COMPANIES INC | 1.1% | 1,809,631 | $58M |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.1% | 1,804,590 | $58M |
| 8 | BlackRock, Inc. | 1.0% | 1,612,750 | $52M |
| 9 | BlackRock, Inc. | 0.9% | 1,461,221 | $47M |
| 10 | AMERIPRISE FINANCIAL INC | 0.7% | 1,048,539 | $34M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Pacs Group Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.7B
Apogee Therapeutics IncAPGE
Special meeting·Aug 11, 2026·$10.1B
Doximity IncDOCS
Annual meeting·Aug 27, 2026·$3.9B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.5B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Reference
Frequently asked questions
- When is the Pacs Group Inc 2025 annual meeting?
- Pacs Group Inc (PACS) holds its 2025 annual shareholder meeting on Friday, December 19, 2025.
- What is the record date for the Pacs Group Inc 2025 meeting?
- The record date for the Pacs Group Inc 2025 meeting is Monday, November 10, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Pacs Group Inc's 2025 meeting?
- The board is presenting 2 director nominees at the Pacs Group Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Pacs Group Inc 2025 meeting?
- Shareholders will vote on 4 proposals at the Pacs Group Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.